how can i qualify for semaglutide Who Prescribe Semaglutide? Prescribers and Online Options Your weight loss journey starts

A meta-analysis of randomized clinical trials specifically evaluating semaglutide did not find an increased risk of acute pancreatitis compared to placebo

Clinical Trial Results STEP Trials (Semaglutide) The STEP program studied semaglutide 2.4 mg weekly in overweight/obese adults: STEP 1 : 16.9% average weight loss over 68 weeks vs 2.4% placebo STEP 2 (T2D patients): 9.6% weight loss STEP 3 (with behavioral therapy): 16.0% weight loss STEP 5 (2-year data): 15.2% sustained weight loss SURMOUNT Trials (Tirzepatide) The SURMOUNT program studied tirzepatide at 5mg, 10mg, and 15mg weekly: SURMOUNT-1 : 20.9% average weight loss at 15mg over 72 weeks vs 3.1% placebo SURMOUNT-2 (T2D patients): 14.7% at 15mg SURMOUNT-3 (with lifestyle intervention): 26.6% at highest dose SURMOUNT-4 (maintenance): continued weight loss vs weight regain on placebo Head-to-Head No large head-to-head trial has directly compared them at optimal doses for weight loss

Home Delivery: Your prescription is sent to a trusted pharmacy, and your medication is shipped right to your door

Because youre likely eating 3040% less food, its no longer enough to simply choose healthy foods, every nutritional decision carries more weight and every meal needs to deliver as much nutrition as possible